News

< Back to News

Events
October 21 2026
Mark Leney to Speak at NCLifeSci Contract R&D Luncheon and Forum

Uniphar is pleased to join the NC Life Sciences Organization for the NCLifeSci Contract R&D Luncheon and Forum: “The Path to Success: Concept to Commercialization” on October 29, 2026.

Mark Leney, Ph.D., Senior Advisor, Science, CMC & Technical Operations at Uniphar Development, will participate as a panelist, sharing insights from more than 25 years of experience supporting drug development across the U.S., Europe, and Asia. His work includes regulatory strategy, CMC development, translational planning, and commercialization readiness.

The discussion will explore the decisions and strategies that can help organizations successfully move from early development toward commercialization, including how to:

  • Turn scientific and commercial goals into clinical and manufacturing plans that can scale
  • Meet regulatory and compliance expectations
  • Balance cost, schedule, and risk across the product development lifecycle

Date: Thursday, October 29, 2026
Time: 11:30 AM – 2:00 PM EDT
Location: NC Biotechnology Center, Durham, NC

Meet the Uniphar Team

Joining Mark Leney at the event will be:

  • Kay Tieman, Vice President, Business Development, Uniphar Clinical
  • Kelly Doggett, Senior Director, Business Operations, Uniphar Development

Attending the forum? Connect with Mark Leney, Kay Tieman, and Kelly Doggett to discuss your development goals and how Uniphar’s expertise can support your path from concept to commercialization.

About Uniphar Development

Uniphar Development provides integrated regulatory, clinical, and strategic development services to biopharmaceutical companies worldwide, with expertise spanning regulatory strategy, FDA engagement, clinical trial design, and development operations. Uniphar Development partners with innovators to accelerate the path from early-stage programs to late-stage clinical development and beyond, with a focus on advancing asset value inflection and supporting efficient use of capital.

About NCLifeSci

NCLifeSci, the North Carolina Life Sciences Organization, advances the North Carolina life sciences industry and ecosystem, enabling its members to innovate and collaborate for success in a global marketplace. NCLifeSci delivers policy and advocacy leadership, future-focused workforce development programs, industry connections, and mission-driven member services. Learn more at https://www.nclifesci.org/.

Is Your Dose Ready
for Phase 3?

Download our free Model-Informed Drug Development Executive Guide
to learn how clinical pharmacology and pharmacometrics can strengthen dose justification and reduce development risk.